Vanguard Group
BRLI

Vanguard Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Vanguard Group’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,841,215
Closed -$76M – 4227
2015
Q2 		$76M Buy
1,841,215
+37,161
+2% +$1.33M 0.01% 1714
2015
Q1 		$63.6M Buy
1,804,054
+83,698
+5% +$2.83M ﹤0.01% 1797
2014
Q4 		$55.3M Buy
1,720,356
+8,059
+0.5% +$233K ﹤0.01% 1785
2014
Q3 		$48M Buy
1,712,297
+13,587
+0.8% +$414K ﹤0.01% 1813
2014
Q2 		$51.3M Sell
1,698,710
-7,519
-0.4% -$208K ﹤0.01% 1821
2014
Q1 		$47.2M Sell
1,706,229
-52,128
-3% -$1.36M ﹤0.01% 1840
2013
Q4 		$44.9M Sell
1,758,357
-62,336
-3% -$1.92M ﹤0.01% 1839
2013
Q3 		$54.4M Buy
1,820,693
+53,503
+3% +$1.49M 0.01% 1671
2013
Q2 		$50.8M Buy
+1,767,190
New +$48.7M 0.01% 1626

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Vanguard Group's BRLI Position: Q3 2015 in Review

Vanguard Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 1,841,215 shares — an estimated $76M sold.

Vanguard Group first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $76M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Vanguard Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Vanguard Group sold 1,841,215 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $76M.
  • Vanguard Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Vanguard Group's BIO-REFERENCE LABS INC-NEW- position peaked at $76M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Vanguard Group's 13F filing for Q3 2015, filed 12 Nov 2015.